Qualigen Therapeutics Inc

NASDAQ:QLGN   3:59:56 PM EDT
1.43
+0.01 (+0.70%)
Earnings Announcements

Qualigen Therapeutics, Inc. Provides Update On Product Development Priorities And Reports Second Quarter And Six Month 2021 Financial Results

Published: 08/17/2021 12:57 GMT
Qualigen Therapeutics Inc (QLGN) - Qualigen Therapeutics, Inc. Provides Update on Product Development Priorities and Reports Second Quarter and Six Month 2021 Financial Results.
Q2 Revenue Rose 24 Percent to $1.1 Million.
Q2 Loss per Share $0.18.
As of June 30, 2021, Co Had $15.2 Million of Cash and Cash Equivalents.